- Clinical Stem Cell Services
- REPROCELL Japan GMP Manufacturing Facility
REPROCELL Japan GMP Facility
Cell-based Product Manufacturing for Clinical Research

The Tonomachi REPROCELL Regenerative Medicine Center is located in the King Skyfront area of Tonomachi, Kawasaki City, Japan. The King Skyfront is a global strategic hub concentrating Japan's most advanced life science industries and research institutions. Positioned directly across from Haneda Airport, the site provides an ideal environment for collaboration with domestic and international research and medical institutions.
GMP Facility for Manufacturing Cell-based Products
Our manufacturing center holds an MHLW license for the production of specified processed cell products (Facility No. FA3200006) under Japan’s Act on the Safety of Regenerative Medicine. This license requires compliance with strict quality, safety, and operational standards. Under this license, we are authorized to perform contract manufacturing of cells for clinical research, all within a fully audited and controlled quality management system
Facility Environment & Rigorous Quality Control
The facility includes multiple cleanrooms with graded air‐cleanliness levels, pressure-controlled zoning, and unidirectional personnel and materials flow to minimize contamination risk. All cell processing is performed in aseptic biological safety cabinets. Environmental controls are continuously monitored (temperature, pressure, and airborne particulates) with real-time deviation alerts. In addition, routine environmental monitoring of airborne, settling, and surface microbial loads is conducted across all classified areas.
Key Manufacturing Experience
Our center has a proven track record in the manufacturing of:
Ask our experts about our GMP services
Discover more
Resources
- FAQ: Clinical iPSCs
- FAQ: Clinical MSCs
- FAQ: iPSC-Derived Exosomes
- Making iPSC-Derived Therapeutics a Clinical Reality – our external article in the European Biopharmaceutical Review.
Gene Editing Services
On the REPROCELL blog
Latest in Stem Cells
REPROCELL Attends Japan-Maryland Night 2026
REPROCELL was honored to attend Japan-Maryland Night on Wednesday March 4th 2026 Maryland State, USA, hosted by the Embassy of Japan (in Washington DC).
06 March 2026
From StemRNA™ Clinical Seed Clone to GMP-Ready Cell Therapy Programs
Discover how REPROCELL’s StemRNA™ Clinical iPSC Seed Clones streamline the path to GMP-ready cell therapy, simplifying regulatory processes and enabling scalable, high-quality manufacturing.
27 February 2026
iPSC-, MSC- and iMSC-Derived Exosome Therapeutics: The Cell-Free Future of Regenerative Medicine
Explore the future of regenerative medicine with iPSC-, MSC-, and iMSC-derived exosome therapeutics, focusing on their advantages, challenges, and clinical potential.
19 November 2025




